Exporter

EN
FR
Carboplatin
Statut de médicament essentiel
Description générale
Carboplatin is a platinum-based antineoplastic agent used to treat many types of cancer.
INN
Carboplatin
Codes ATC
L01XA02
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 2009 (TRS 958) pour Other specified carcinomas of ovary
Modifié en 2009 (TRS 958) pour Retinoblastoma
Modifié en 2021 (TRS 1035) pour Germ cell tumour of testis
Wikipédia
Carboplatin
DrugBank
Carboplatin
Recommandations
Section
Cytotoxic medicines
  • Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL
  • Parenteral > General injections > IV: 600 mg per 60 mL; 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL
  • Parenteral > General injections > IV: 600 mg per 60 mL; 450 mg per 45 mL; 50 mg per 5 mL; 150 mg per 15 mL
  • Parenteral > General injections > IV: 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL; 50 mg per 5 mL
  • Parenteral > General injections > IV: 150 mg per 15 mL; 50 mg per 5 mL; 450 mg per 45 mL; 600 mg per 60 mL
Indications
Other specified carcinomas of ovary Retinoblastoma Osteosarcoma of bone or articular cartilage of unspecified sites Malignant neoplasms of breast Malignant neoplasms of nasopharynx Other specified malignant neoplasms of bronchus or lung Malignant neoplasms of cervix uteri Other specified gliomas of brain Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx Malignant neoplasms of kidney, except renal pelvis Other specified malignant neoplasms of the ovary Germ cell tumour of testis Malignant neoplasms of nasopharynx Malignant neoplasms of hypopharynx Malignant neoplasms of oropharynx